IP Library Granted Patent US 10,377,697
Granted Patent B2
US 10,377,697 · App. 15/780,957 · Granted Aug 13, 2019

Process and intermediates

Inventors: Florian Karl Kleinbeck-Riniker (Basel, CH); Benjamin Martin (Basel, CH); Gerhard Penn (Basel, CH); Francesco Venturoni (Basel, CH); Thierry Schlama (Basel, CH); Thomas Ruch (Basel, CH); Thomas Allmendinger (Basel, CH); Bernhard Wietfeld (Basel, CH); Paolo Filipponi (Basel, CH)
Assignee: Novartis AG
C07C69/738C07C51/373C07C59/84C07C67/035C07C229/34C07C251/40C07C251/66C07C313/06C07D207/36C07D265/02C07B2200/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,377,697
App. No.
15/780,957
Granted
Aug 13, 2019
Kind
B2
Abstract

The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.

Claims (41)

1. A compound of formula (XV), or a salt thereof

wherein:

R5 is selected from the group consisting of hydrogen and a group CO—OR*, and

Ra and R* are, independently of each other, selected from the group consisting of hydrogen, a carboxyl protecting group, and C 1 -C 6 -alkyl.

2. The compound of formula (XV) according to claim 1 , wherein

a) the compound is of formula (I), or a salt thereof;

wherein:

Ra is selected from the group consisting of hydrogen, a carboxyl protecting group, and C 1 -C 6 -alkyl, or

b) the compound is of formula (II), or a salt thereof;

wherein:

Ra and R* are, independently of each other, selected from the group consisting of hydrogen, a carboxyl protecting group, and C 1 -C 6 -alkyl.

3. A process for the manufacture of a compound of formula (I), or a salt thereof;

wherein:

Ra is selected from the group consisting of hydrogen, a carboxyl protecting group and C 1 -C 6 -alkyl, comprising reacting a compound of formula (II), or a salt thereof,

wherein:

Ra and R* are, independently of each other, selected from the group consisting of hydrogen, a carboxyl protecting group, and C 1 -C 6 -alkyl, under—if required—deprotection reaction conditions, followed by decarboxylation reaction conditions, and optionally by introduction of a moiety Ra selected from the group consisting of a carboxyl protecting group and C 1 -C 6 -alkyl, to provide the compound of formula (I).

4. The process according to claim 3 , wherein the compound of the formula (II), or a salt thereof

wherein:

Ra and R* are, independently of each other, selected from the group consisting of hydrogen, a carboxyl protecting group, and C 1 -C 6 -alkyl, is prepared by a process comprising reacting a compound of formula (III),

wherein:

R* is selected from the group consisting of a carboxyl protecting group and C 1 -C 6 -alkyl, with a propionate derivative of formula (IV),

wherein:

X is a leaving group and Ra is selected from the group consisting of a carboxyl protecting group and C 1 -C 6 -alkyl, and, if required, replacing the carboxyl protecting groups R* and Ra with a group selected from the group consisting of hydrogen and C 1 -C 6 -alkyl, to provide the compound of formula (II).

5. The process according to claim 4 , wherein the compound of the formula (III),

wherein R* is selected from the group consisting of a carboxyl protecting group, and C 1 -C 6 -alkyl, is prepared by a process comprising reacting a compound of formula (V),

or a reactive derivative thereof, with a salt of a malonic acid half ester of formula (VI),

wherein R* is selected from the group consisting of a carboxyl protecting group and C 1 -C 6 -alkyl.

6. A process for the manufacture of a compound of formula (I), or a salt thereof;

wherein:

Ra is selected from the group consisting of hydrogen, a carboxyl protecting group, and C 1 -C 6 -alkyl, comprising reacting an activated dianionic derivate of the compound of formula (V), or a salt thereof,

with a compound of formula (XIV), or a salt thereof

wherein:

Rf is selected from the group consisting of

—O—R* wherein R* is selected from the group consisting of a carboxyl protecting group and C 1 -C 6 -alkyl,

—N(CH 3 )—O(CH 3 ),

morpholinyl, and

imidazolinyl,

in the presence of a base, and followed by a decarboxylation reaction, to obtain compound of formula (I), or a salt thereof wherein Ra is hydrogen, optionally followed by reacting the obtained compound of formula (I), or a salt thereof, wherein Ra is hydrogen, with an agent introducing a carboxyl protecting group, to provide the compound of formula (I), wherein Ra is a carboxyl protecting group, and/or

optionally followed by reacting the compound of the formula (I), or a salt thereof, wherein Ra is hydrogen, with a coupling reagent in the presence of an C 1 -C 6 -alkanol, to provide the compound of formula (I), wherein Ra is C 1 -C 6 -alkyl.

7. The process according to claim 5 , wherein the compound of formula (V),

is prepared by a process comprising hydrolysing a cyanide of the formula (VII)

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: MARTIN, BENJAMIN; PENN, GERHARD; VENTURONI, FRANCESCO; KLEINBECK-RINIKER, FLORIAN KARL
To: NOVARTIS PHARMA AG
Reel/Frame 047748/0354 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 047748/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: KLEINBECK-RINIKER, FLORIAN KARL; MARTIN, BENJAMIN; PENN, GERHARD; VENTURONI, FRANCESCO; SCHLAMA, THIERRY; RUCH, THOMAS; ALLMENDINGER, THOMAS; WIETFELD, BERNHARD; FILIPPONI, PAOLO
To: NOVARTIS PHARMA AG
Reel/Frame 047748/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 047788/0483 →
Priority Claims (2)
EP 15199378 · Dec 10, 2015 · regional
EP 16198655 · Nov 14, 2016 · regional
Continuity (1)
Related Publication 20180354889A1 · Dec 13, 2018